Stock listing

OTC:RGRX RegeneRx Biopharmaceuticals, Inc. Stock

Follow RegeneRx Biopharmaceuticals, Inc. into a list and get an email when it puts out news.

Share price · OTC:RGRX

$0.0011 USD 0.0000 (0.0%)

Close on Oct 30, 2026

Past year +450.0% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
$0.0011 – $0.0011 USDOct 30, 2026
Market cap
—Left out: price × shares is far from the company's reported size
52-week range
$0.0002 – $0.1630 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
$0 USDMedian day 0 shares · 60 days with no trades · last 3 months, Jul 30, 2026 – Oct 30, 2026
RegeneRx Biopharmaceuticals, Inc. logo

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · OTC:RGRX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.0011251
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.1580$0.1580$0.00111,292
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.1610$0.1610$0.0011252
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.00110.00000.0%$0.0011$0.0011$0.00110
$0.0011+0.0004+57.1%$0.0011$0.0011$0.0011726
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.0007155
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.0007160
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.0007+0.0001+16.7%$0.0007$0.0007$0.0007485
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.00060.00000.0%$0.0006$0.0006$0.00060
Ticker
OTC:RGRX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

RegeneRx Biopharmaceuticals, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
Decks
8 decks · latest November 2021

Valuation

price Oct 30, 2026

Enterprise value
No market cap
P/E
No market cap
EV/sales
No market cap
EV/EBITDA
No market cap
Price/book
No market cap
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
0.23

Team and board

Officers

OfficerRole
Allan L. GoldsteinChairman of our Board of Directors and Chief Scientific Advisor

Board

DirectorRole
Allan L. GoldsteinChairman of our Board of Directors and Chief Scientific Advisor
Alessandro NosedaDirector
Don ElseyMember of our Board of Directors
Joseph C. McnayDirector
Mauro BoveMember of our Board of Directors

Events

QuarterResults
Quarter to Sep 30, 2023Nov 10, 2023
Quarter to Jun 30, 2023Aug 4, 2023
Q1 2023Apr 11, 2023
Q4 2022Mar 29, 2023
Q3 2022Nov 14, 2022
Q2 2022Aug 5, 2022
Q1 2022May 17, 2022
Q4 2021Mar 30, 2022
Q3 2021Nov 12, 2021
Q2 2021Aug 6, 2021
All 12 quarters
QuarterResults
Q1 2021May 18, 2021
Q4 2020Mar 31, 2021

Open Events

Decks

DeckKindSlidesDate
Shareholder Meeting (November 2021)Shareholder meeting17 slidesNovember 2021
The Fall Investor Summit 2019Conference18 slidesSep 16, 2019
Rodman & Renshaw 18th Annual Global Investment Conference 2016Conference28 slidesSep 12, 2016
Shareholder Meeting (September 2014)Shareholder meeting15 slidesSep 15, 2014
Shareholder Meeting (July 2010)Shareholder meeting13 slidesJul 14, 2010
Investor Presentation (October 2008)Investor deck31 slidesOct 30, 2008
Shareholder Meeting (July 2008)Shareholder meeting19 slidesJul 2, 2008
Investor Presentation (January 2006)Investor deck48 slidesJan 25, 2006

Open Decks

Financials

Annual, in USD

Income statement

LineFY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013
Revenue76.8K76.8K76.8K76.8K69.7K56.7K93.3K60.6K029.0K
Cost of revenue65.1K81.0K143.9K237.3K203.2K367.3K938.0K
Gross profit76.8K-11.4K-87.3K-144.0K-142.6K-367.3K-909.0K
Research and development06.64K4.92K65.1K81.0K143.9K237.3K203.0K367.0K189.0K
Selling, general and administrative1.48M1.40M1.37M1.27M1.31M1.36M1.53M1.57M1.55M
Operating income-1.40M-1.33M-1.29M-1.26M-1.32M-1.44M-1.67M-1.71M-1.56M
Depreciation and amortization1.42K2.75K3.05K3.33K3.40K4.82K
EBITDA-1.26M-1.32M-1.44M-1.67M-1.71M-1.55M
Interest expense325.6K324.9K232.6K153.4K87.3K00000
Income before tax-1.73M-1.60M-1.52M-1.40M-1.99M385.1K229.1K-5.27M-2.75M
Income tax098.6K000
Net income-1.73M-1.60M-1.52M-1.40M-1.99M286.5K229.1K-5.27M-2.75M
Earnings per share, basic-1.20-0.01-0.01-0.01-0.020.00

Balance sheet

LineFY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013
Cash and equivalents290.9K1.23M427.9K639.9K237.3K181.7K769.5K317.6K844.0K6.00K
Current assets306.9K1.25M477.8K681.6K273.9K217.2K849.4K341.9K930.6K
Property, plant and equipment27.7K68.2K24.5K1.42K4.17K7.22K10.5K13.0K4.00K
Total assets382.2K1.28M551.8K711.8K281.0K227.1K862.4K358.2K949.0K43.0K
Accounts payable63.8K63.6K39.3K43.7K92.4K66.5K75.7K141.1K233.0K577.0K
Current liabilities553.7K429.9K399.6K242.5K315.0K2.15M659.8K359.0K410.0K616.0K
Long-term debt1.37M1.14M923.8K708.1K43.8K512.0K688.9K566.0K432.0K
Total liabilities3.83M3.51M3.38M3.05M2.49M4.34M6.93M7.10M2.66M1.66M
Shareholders' equity-3.45M-2.23M-2.82M-2.34M-2.21M-4.12M-6.07M-6.74M-1.71M-1.62M
Shares outstanding1.44M143.5M133.4M131.5M128.4M109.8M

Cash flow

LineFY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013
Cash from operations-940.7K-990.3K-1.01M-1.14M-888.3K-663.1K-1.07M-525.3K-1.70M
Capital spending0000000-1.08K-13.0K0
Free cash flow-940.7K-990.3K-1.01M-1.14M-888.3K-663.1K-1.07M-526.4K-1.72M
Cash from investing-1.08K-13.3K
Cash from financing01.79M794.9K1.54M943.8K75.3K1.52M1.52M2.56M646.0K
Share buybacks75.3K1.52M1.52M2.50M
Change in cash-940.7K803.7K-212.0K402.7K55.6K-587.8K451.9K-526.4K837.7K

Open Financials

Cap table

Built by 6ix from RegeneRx Biopharmaceuticals, Inc.’s releases

Common shares
1,496,966
Fully diluted
1,496,966

Fully diluted

LineShares
Common shares1,496,966

Share count over time

CountShares
Nov 22, 20261,496,966

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Don Elsey
Other companies: BullFrog AI Holdings, Inc. (Director · Since at least Feb 13, 2023); Lyra Therapeutics, Inc. (CFO, Treasurer & Secretary · Apr 30, 2020 – Feb 8, 2021 · Past); CapForce Inc. (Director · Feb 21, 2019 – Jun 7, 2023 · Past); Senseonics Holdings, Inc. (CFO, Secretary and Treasurer · Apr 12, 2016 – Feb 2, 2018 · Past)
Member of our Board of Directors · Since at least Sep 1, 2017
Alessandro NosedaDirector · Since at least May 15, 2019
Allan L. GoldsteinChairman of our Board of Directors and Chief Scientific Advisor · Since at least Oct 19, 2017
Joseph C. McnayDirector · Since at least Nov 5, 2026
Mauro BoveMember of our Board of Directors · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about RegeneRx Biopharmaceuticals, Inc.